Table 2 Experimental groups for immunogenicity trial.

From: Targeted-pig trial on safety and immunogenicity of serum-derived extracellular vesicles enriched fractions obtained from Porcine Respiratory and Reproductive virus infections

Group

Pigs

Priming antigen

Boost antigen

Adjuvant

Route

PBS

5

PBS

PBS

N/A

IM

Group A

7

Exosomes (1 mg)/two doses

Viral peptides (300 ug each)/one dose

Montanide ISA 206vg

IM

Group B

7

Exosomes (1 mg)/two doses

Viral peptides (300 ug each)/one dose

Montanide ISA 206vg

IM

Group C

7

Viral peptides (500 ug each/two doses)

Viral peptides (300 ug each)/one dose

Montanide ISA 201 vg

IM

Group D

7

Viral peptides (500 ug each/two doses)

Viral peptides (300 ug each)/one dose

Montanide ISA 206 vg

IM